Putnam Global Health Care A PHSTX

Medalist Rating as of | See Franklin Templeton Investment Hub
  • NAV / 1-Day Return 66.35  /  −0.08 %
  • Total Assets 1.9 Bil
  • Adj. Expense Ratio
    1.070%
  • Expense Ratio 1.070%
  • Distribution Fee Level Low
  • Share Class Type Front Load
  • Category Health
  • Investment Style Large Blend
  • Min. Initial Investment 0
  • Status Open
  • TTM Yield 0.15%
  • Turnover 41%

USD | NAV as of Oct 02, 2024 | 1-Day Return as of Oct 02, 2024, 10:24 PM GMT+0

Morningstar’s Analysis PHSTX

Will PHSTX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Increased confidence in Putnam Global Health Care A's prospects relative to its Morningstar Category peers results in an upgrade in this strategy's Morningstar Medalist Rating to Neutral from Negative.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-highest quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings PHSTX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 61.0
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Eli Lilly and Co

10.36 201.9 Mil
Healthcare

UnitedHealth Group Inc

9.45 184.2 Mil
Healthcare

AbbVie Inc

7.45 145.1 Mil
Healthcare

AstraZeneca PLC

6.65 129.6 Mil
Healthcare

Innoviva Inc

5.28 102.9 Mil
Healthcare

Novo Nordisk AS Class B

5.04 98.1 Mil
Healthcare

Intuitive Surgical Inc

5.01 97.6 Mil
Healthcare

Thermo Fisher Scientific Inc

4.38 85.4 Mil
Healthcare

Johnson & Johnson

3.71 72.3 Mil
Healthcare

Roche Holding AG

3.63 70.8 Mil
Healthcare

Sponsor Center